Molecular Diagnostics Market Size is Expected to Reach USD 43.50 Billion by 2035 Owing to the Surging Demand for Accurate and Early Disease Detection Globally | SNS Insider

U.S. Molecular Diagnostics Market size was valued at USD 5.0 Billion in 2025 and is projected to reach USD 8.07 Billion by 2035 due to increasing chronic diseases in the country.Austin, April 03, 2026 ...
app.com

FamilyTreeDNA Advances Genetic Genealogy with Precision Genomics Partnership

HOUSTON, TX, UNITED STATES, February 24, 2026 /EINPresswire.com/ — FamilyTreeDNA, the company that pioneered the genetic genealogy industry, today announced a ...
Frontiers

From bench to bytes: a practical guide to RNA sequencing data analysis

RNA sequencing (RNA-Seq) is a high-throughput sequencing approach that enables comprehensive quantification of transcriptomes at a genome-wide scale. As a result, RNA-Seq has become a routine ...
GEN

Efficiency, Sustainability Drive Thermo Fisher’s New Microarray Data Analysis Solution

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
Frontiers

Exome sequencing and prenatal skeletal abnormalities: comprehensive review and meta-analysis and way forward

To assess the detection rate of exome sequencing (ES) in fetuses diagnosed as skeletal abnormalities (SKA) with normal karyotype or chromosomal microarray analysis (CMA) results. We conducted ...
BioSpace

CD Genomics Unveils Advanced LncRNA Microarray Service to Accelerate Transcriptomic Research

CD Genomics, a globally distinguished pioneer in genomic technologies, declared today the induction of their innovative LncRNA Microarray Service, affording scientists an avant-garde solution for ...
Scientific Research Publishing

Squassina, A., Manchia, M., Congiu, D., Chillotti, C., Ardau, R. and Del Zompo, M. (2011) The Use of Gene Expression Microarrays and Whole Exome Sequencing in Lithium ...

ABSTRACT: Lithium has long been established as a first-line mood stabilizer in the treatment of bipolar disorder and treatment-resistant depression. In addition to its psychiatric applications, ...
Business Wire

Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics

SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...